Status:
UNKNOWN
Care Transitions in Renal Disease Patients
Lead Sponsor:
Fresenius Medical Care North America
Collaborating Sponsors:
Amgen
Conditions:
Renal Disease
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this pilot is to reduce the 30-day hospital readmission rate for dialysis patients. It is a quality improvement project that consistent of 4 "tracks." Tracks 1 \& 2: Implement use of check...
Eligibility Criteria
Inclusion
- Chronic hemodialysis patients
- All patients admitted to the hospital during the study period
Exclusion
- Patients \<18 years old
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
3300 Patients enrolled
Trial Details
Trial ID
NCT01842776
Start Date
March 1 2013
End Date
December 1 2014
Last Update
April 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fresenius
Franklin, Tennessee, United States, 37067